{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:55:14Z","timestamp":1780340114931,"version":"3.54.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jaut.2012.03.001","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T12:33:07Z","timestamp":1336480387000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Subgroups of Sj\u00f6gren syndrome patients according to serological profiles"],"prefix":"10.1016","volume":"39","author":[{"given":"Vasiliki-Kalliopi","family":"Bournia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis G.","family":"Vlachoyiannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2012.03.001_bib1","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2012.03.001_bib2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2012.03.001_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12016-007-8003-8","article-title":"Sjogren's syndrome\u2013study of autoantigens and autoantibodies","volume":"32","author":"Routsias","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1083\/jcb.125.5.981","article-title":"Analysis of the intracellular localization and assembly of Ro ribonucleoprotein particles by microinjection into Xenopus laevis oocytes","volume":"125","author":"Simons","year":"1994","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jaut.2012.03.001_bib8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/nar\/27.4.1070","article-title":"Conserved features of Y RNAs revealed by automated phylogenetic secondary structure analysis","volume":"27","author":"Farris","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaut.2012.03.001_bib9","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/MCB.01060-06","article-title":"Functional requirement of noncoding Y RNAs for human chromosomal DNA replication","volume":"26","author":"Christov","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaut.2012.03.001_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-1119(95)00695-8","article-title":"The Caenorhabditis elegans rop-1 gene encodes the homologue of the human 60-kDa Ro autoantigen","volume":"167","author":"Labbe","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2012.03.001_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00109-004-0529-0","article-title":"The Ro 60\u00a0kDa autoantigen: insights into cellular function and role in autoimmunity","volume":"82","author":"Chen","year":"2004","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jaut.2012.03.001_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2005.03.009","article-title":"Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity","volume":"121","author":"Stein","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2012.03.001_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib14","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib15","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib16","doi-asserted-by":"crossref","unstructured":"Higgs R, Lazzari E, Wynne C, Ni Gabhann J, Espinosa A, Wahren-Herlenius M, et\u00a0al. Self protection from anti-viral responses\u2013Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors. PLoS One;5:e11776.","DOI":"10.1371\/journal.pone.0011776"},{"key":"10.1016\/j.jaut.2012.03.001_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an Interferon Inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1261\/rna.1478709","article-title":"A\u00a0comprehensive analysis of the La-motif protein superfamily","volume":"15","author":"Bousquet-Antonelli","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.jaut.2012.03.001_bib19","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1073\/pnas.93.8.3383","article-title":"Transcription termination factor La is also an initiation factor for RNA polymerase III","volume":"93","author":"Maraia","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2012.03.001_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaut.2010.06.016","article-title":"B-cell epitopes of the intracellular autoantigens Ro\/SSA and La\/SSB: tools to study the regulation of the autoimmune response","volume":"35","author":"Routsias","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.03.001_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren's syndrome: a retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"ter Borg","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaut.2012.03.001_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2012.03.001_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic Sjogren's syndrome","author":"Martel","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2004.12.002","volume":"4","author":"Locht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2012.03.001_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/32.6.449","article-title":"Detection of anti-ro(ssa) antibodies in autoimmune diseases: comparison of five methods","volume":"32","author":"Manoussakis","year":"1993","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2012.03.001_bib27","first-page":"1283","article-title":"Differential expression of Ro\/SSA 60 kDa and La\/SSB, but not Ro\/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjogren's syndrome","volume":"34","author":"Barcellos","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/jaut.1999.0333","article-title":"Autoantibodies to La\/SSB in patients with primary Sjogren's syndrome (pSS) are associated with upregulation of La\/SSB mRNA in minor salivary gland biopsies (MSGs)","volume":"13","author":"Tzioufas","year":"1999","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.03.001_bib29","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V","article-title":"Detection of anti-Ro\/SSA and anti-La\/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome","volume":"41","author":"Tengner","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0896-8411(89)90189-3","article-title":"Autoantibody synthesis in salivary glands of Sjogren's syndrome patients","volume":"2","author":"Horsfall","year":"1989","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.03.001_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0714.2004.00301.x","article-title":"Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome","volume":"34","author":"Hammi","year":"2005","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.jaut.2012.03.001_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sjogren's syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.03.001_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00296-005-0596-8","article-title":"Sjogren's syndrome in the community: can serology replace salivary gland biopsy?","volume":"26","author":"Kessel","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2012.03.001_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.61.5.398","article-title":"Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro\/SSA, La\/SSB and their linear epitopes in primary Sjogren's syndrome (pSS): a European multicentre study","volume":"61","author":"Tzioufas","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2007.03337.x","article-title":"Clinical significance of autoantibodies recognizing Sjogren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjogren's syndrome","volume":"148","author":"Goeb","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2003.028340","article-title":"Anti-Ro\/SSA and anti-La\/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome","volume":"88","author":"Toker","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2012.03.001_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/rheumatology\/36.9.969","article-title":"Quantitative assessment of salivary gland inflammatory infiltration in primary Sjogren's syndrome: its relationship to different demographic, clinical and serological features of the disorder","volume":"36","author":"Gerli","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib38","first-page":"2044","article-title":"Serological implications of germinal center-like structures in primary Sjogren's syndrome","volume":"34","author":"Jonsson","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib40","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The Importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a Prospective study of 186 antibody-Exposed Fetuses and Infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaut.2012.03.001_bib41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.3458307","article-title":"Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome","volume":"232","author":"Harley","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jaut.2012.03.001_bib42","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1756-185X.2009.01444.x","article-title":"Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome","volume":"13","author":"Huo","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib44","doi-asserted-by":"crossref","DOI":"10.3109\/s10165-011-0446-3","article-title":"Cigarette smoking in primary Sjogren's syndrome: positive association only with ANA positivity","author":"Karabulut","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib45","first-page":"158","article-title":"Comparison of rheumatoid test procedures\u2013value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability","volume":"55","author":"Aupperle","year":"1996","journal-title":"Z\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A\u00a0longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03009740802366043","article-title":"IgA rheumatoid factor in primary Sj\u00f6gren's syndrome","volume":"38","author":"Peen","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.blre.2006.12.002","article-title":"Cryoglobulinemia","volume":"21","author":"Tedeschi","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.jaut.2012.03.001_bib49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortalityof primary Sj\u00f6gren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sj\u00f6gren's syndrome: identification of prognostic factors","volume":"46","author":"Brito-Zer\u00f3n","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2012.03.001_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib52","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.2004.029603","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Tobon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib53","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2012.03.001_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","article-title":"Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies","volume":"36","author":"Iwamoto","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib55","first-page":"608","article-title":"Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjogren's syndrome","volume":"34","author":"Barcelos","year":"2009","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jaut.2012.03.001_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2012.03.001_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM195801232580407","article-title":"Primary biliary cirrhosis showing a high titer of autoantibody; report of a case","volume":"258","author":"Mackay","year":"1958","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2012.03.001_bib58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1258\/0004563021902008","article-title":"Detection of serum M2 anti-mitochondrial antibodies by enzyme-linked immunosorbent assay is potentially less specific than by immunofluorescence","volume":"39","author":"Patel","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jaut.2012.03.001_bib59","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaut.2012.03.001_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/bega.2000.0105","article-title":"Autoimmune tests in primary biliary cirrhosis","volume":"14","author":"Strassburg","year":"2000","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaut.2012.03.001_bib61","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.03.001_bib62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.0954-6820.1988.tb19634.x","article-title":"Clinical and immunological features of Sj\u00f6gren's syndrome in patients with primary biliary cirrhosis with Emphasis on focal sialadenitis","volume":"224","author":"Hansen","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jaut.2012.03.001_bib63","first-page":"2012","article-title":"Prevalence and longterm course of primary biliary cirrhosis in primary Sjogren's syndrome","volume":"35","author":"Hatzis","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-3083.2002.01165.x","article-title":"Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up","volume":"56","author":"Csepregi","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib65","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(94)80007-3","article-title":"Autoimmune liver disease in patients with primary Sjogren's syndrome","volume":"20","author":"Lindgren","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/rheumatology\/33.8.745","article-title":"Liver involvement in primary Sjogren's syndrome","volume":"33","author":"Skopouli","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib67","first-page":"1453","article-title":"Sjogren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases","volume":"17","author":"Fujikura","year":"1990","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00918090","article-title":"Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases","volume":"12","author":"Zurgil","year":"1992","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/03009747909114450","article-title":"Auto-antibodies in Sjogren's syndrome. With special reference to liver-cell membrane antibody (LMA)","volume":"8","author":"Manthorpe","year":"1979","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib70","first-page":"1593","article-title":"Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome","volume":"33","author":"Ramos-Casals","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib71","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1601-0825.2006.01292.x","article-title":"Sjogren's syndrome: why autoimmune epithelitis?","volume":"12","author":"Mitsias","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib72","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.03.001_bib73","first-page":"582","article-title":"Autoimmune hepatitis in patients with primary Sjogren's syndrome: a series of two-hundred and two patients","volume":"3","author":"Karp","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jaut.2012.03.001_bib74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1827.2005.01790.x","article-title":"Autoimmune hepatitis in primary Sj\u00f6gren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sj\u00f6gren's syndrome","volume":"55","author":"Matsumoto","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.jaut.2012.03.001_bib75","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","article-title":"Anti-CENP-H antibodies in patients with Sjogren\u2019s syndrome","volume":"26","author":"Hsu","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2012.03.001_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-8981(02)00419-9","article-title":"Antibodies to centromere antigens measured by an automated enzyme immunoassay","volume":"328","author":"Gonz\u00e1lez-Buitrago","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaut.2012.03.001_bib77","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.cca.2011.06.041","article-title":"Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA","volume":"412","author":"Mahler","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaut.2012.03.001_bib78","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0248-8663(10)80020-7","article-title":"Anti-centromere antibodies. Study of 67 positive sera","volume":"13","author":"Renier","year":"1992","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaut.2012.03.001_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","article-title":"Patients with anticentromere antibodies, clinical features, diagnoses and evolution","volume":"32","author":"Vlachoyiannopoulos","year":"1993","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2012.03.001_bib80","first-page":"1488","article-title":"Clinical and serological heterogeneity in patients with anticentromere antibodies","volume":"32","author":"Miyawaki","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib81","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sjogren's Syndrome: a retrospective descriptive analysis","volume":"12","author":"Bournia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2012.03.001_bib82","first-page":"2253","article-title":"Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome","volume":"34","author":"Salliot","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib83","first-page":"785","article-title":"Sjogren's syndrome with anticentromere antibodies","volume":"64","author":"Caramaschi","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.jaut.2012.03.001_bib84","first-page":"2238","article-title":"Clinical and laboratory features of anticentromere antibody positive primary Sjogren's syndrome","volume":"28","author":"Katano","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2474-11-140","article-title":"Anti-centromere antibody-seropositive Sjogren's syndrome differs from conventional subgroup in clinical and pathological study","volume":"11","author":"Nakamura","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jaut.2012.03.001_bib86","article-title":"Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjogren's syndrome","author":"Kitagawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib87","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary Sj\u00f6gren\u2019s syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib88","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib89","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10067-009-1359-9","article-title":"Primary Sjogren's syndrome with anticentromere antibodies\u2013a clinically distinct subset","volume":"29","author":"Gulati","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib90","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/rheumatology\/ker118","article-title":"Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndrome","volume":"50","author":"Pertovaara","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.03.001_bib91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0923-1811(99)00032-8","article-title":"A\u00a0study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases","volume":"21","author":"Ono","year":"1999","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaut.2012.03.001_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.1780350112","article-title":"Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases","volume":"35","author":"Itoh","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1386-6346(00)00128-5","article-title":"Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgrounds","volume":"20","author":"Ueno","year":"2001","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jaut.2012.03.001_bib94","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/0016-5085(95)90143-4","article-title":"Antibodies to carbonic anhydrase in patients with immune cholangiopathies","volume":"108","author":"Gordon","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.03.001_bib95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2007-960498","article-title":"Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease","volume":"115","author":"Alver","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jaut.2012.03.001_bib96","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.154.9.4865","article-title":"Induction of experimental autoimmune sialoadenitis by immunization of PL\/J mice with carbonic anhydrase II","volume":"154","author":"Nishimori","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib97","first-page":"278","article-title":"Renal involvement and followup of 130 patients with primary Sj\u00f6gren's syndrome","volume":"35","author":"Ren","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2012.03.001_bib98","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.80.9.2752","article-title":"Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification","volume":"80","author":"Sly","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2012.03.001_bib99","doi-asserted-by":"crossref","first-page":"p63","DOI":"10.1159\/000104873","article-title":"Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjogren's syndrome","volume":"106","author":"Takemoto","year":"2007","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.jaut.2012.03.001_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.2006.00368.x","article-title":"Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function","volume":"26","author":"Eglen","year":"2006","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1016\/j.jaut.2012.03.001_bib101","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.2174\/138161206778522056","article-title":"Muscarinic acetylcholine receptors","volume":"12","author":"Ishii","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaut.2012.03.001_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-3623(94)90021-3","article-title":"Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjorgen's syndrome","volume":"25","author":"Iwabuchi","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jaut.2012.03.001_bib103","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/jphysiol.2004.064626","article-title":"M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice","volume":"558","author":"Nakamura","year":"2004","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jaut.2012.03.001_bib104","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1254\/jjp.78.373","article-title":"(+\/\u2212)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors","volume":"78","author":"Iga","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jaut.2012.03.001_bib106","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2012.03.001_bib107","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody\u2013mediated secretory dysfunction in NOD mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib108","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/labinvest.3700173","article-title":"Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome","volume":"84","author":"Li","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaut.2012.03.001_bib109","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib110","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1002\/art.20625","article-title":"Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder","volume":"50","author":"Wang","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","article-title":"Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome","volume":"59","author":"Cavill","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib112","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/art.20371","article-title":"Detection of anti\u2013type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sj\u00f6gren's syndrome patients by use of a transfected cell line assay","volume":"50","author":"Gao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib113","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.30282","article-title":"Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjogren's syndrome","volume":"63","author":"Park","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.03.001_bib114","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-230X-10-120","article-title":"Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis","volume":"10","author":"Berg","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaut.2012.03.001_bib115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clim.2008.04.001","article-title":"Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjogren's syndrome","volume":"128","author":"Kovacs","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-1838(94)90064-7","article-title":"Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications","volume":"47","author":"Goin","year":"1994","journal-title":"J\u00a0Auton Nerv Syst"},{"key":"10.1016\/j.jaut.2012.03.001_bib117","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1172\/JCI114888","article-title":"Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy","volume":"86","author":"Magnusson","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2012.03.001_bib118","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","article-title":"Anti-SSA\/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block","volume":"30","author":"Eftekhari","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2012.03.001_bib119","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/rheumatology\/ken064","article-title":"Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients","volume":"47","author":"Koo","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.03.001_bib120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2004.11.005","article-title":"A\u00a0peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome","volume":"24","author":"Marczinovits","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.03.001_bib121","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/rheumatology\/keh672","article-title":"Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome","volume":"44","author":"Kovacs","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.03.001_bib122","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/bioinformatics\/17.9.849","article-title":"The HMMTOP transmembrane topology prediction server","volume":"17","author":"Tusnady","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaut.2012.03.001_bib123","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/rheumatology\/keq420","article-title":"Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome","volume":"50","author":"He","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.03.001_bib124","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2007.072421","article-title":"High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sj\u00f6gren syndrome","volume":"67","author":"Nakamura","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.2010.129049","article-title":"Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome","volume":"70","author":"Roescher","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.03.001_bib127","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/rheumatology\/keh389","article-title":"Putative anti-muscarinic antibodies cannot be detected in patients with primary Sj\u00f6gren's syndrome using conventional immunological approaches","volume":"43","author":"Dawson","year":"2004","journal-title":"Rheumatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841112000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841112000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:05:33Z","timestamp":1760256333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841112000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":127,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0896841112000364"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2012.03.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2012.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}